Adenosine and dipyridamole in nuclear imaging: pharmacoeconomic considerations

References

• Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 101(12), 1465–1478 (2000).
   PubMedGoogle Scholar
• •Comprehensive overview of nuclear imaging in coronary artery disease.
   Google Scholar
• Adenoscan® product information, Fujisawa Inc., Deerfield, IL, USA (2000).
   Google Scholar
• Dipyridamole product information, Boehringer Ingelheim Pharmaceuticals Corp., Ridgefield, CT, USA (2002).
   Google Scholar
• Kim C, Kwok YS, Heagerty P, Redberg R Pharmacologic stress testing for coronary disease diagnosis: meta-analysis. Am. Heart J. 142(6), 934–944 (2001).
   PubMedGoogle Scholar
• •Meta-analysis of sensitivity and specificity of adenosine and dipyridamole in SPECT imaging and echocardiography.
   Google Scholar
• Red Book 192002' Drug Topics Thomson Medical Economics Co., Montvale, NJ, USA (2002)
   Google Scholar
• Johnston DL, Daley JR, Hodge DO, Hopfenspirger MR, Gibbons RJ. Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing: a comparison in 2000 patients. Mayo Clin. Proc. 70(4), 331–336 (1995).
   Google Scholar
• •Comparison of adverse events with adenosine and dipyridamole.
   Google Scholar
• Hilleman DE, Lucas BD, Mohiuddin SM, Holmberg MJ. Cost-minimization analysis of iv. adenosine and dipyridamole in thallous chloride 201TI SPECT myocardial perfusion imaging. Ann. Pharmacother. 31(19), 974–979 (1997).
   Google Scholar
• Holmberg MJ, Mohiuddin SM, Hilleman DE, Lucas BD, Wadibia EC. Outcomes and costs of positron emission tomography: comparison of iv. adenosine and iv. dipyridamole. Clin. Ther 19(3), 570–580 (1997).
   Google Scholar
• Reddy P, Coleman CI, Ahlberg AW et al. Cost-effectiveness of adenosine and dipyridamole in technetium-99m sestamibi single photon computed tomography imaging. Value Health 5(3), 128 (2002).
   Google Scholar
• Mayo Clinic Cardiovascular Working Group on Stress Testing. Cardiovascular stress testing: a description of the various types of stress tests and indications for their use. Mayo Clin. Proc. 71(1), 43–52 (1996).
   Google Scholar
• Cohen MC. A snapshot of nuclear cardiology in the United States. Am Soc. NuclCardiol. 5,13 (1998).
   Google Scholar
• Travin MI, Wexler JP. Pharmacological stress testing. Seim Nuc. Med 29(4), 298–318 (1999).
   Google Scholar
• Taillefer R, Bernier H, Lambert R eta]. Comparison between Tc-99m sestamibi and Tc-99m tetrofosmin SPECT imaging with dipyridamole in detection of coronary artery disease.' Nucl. Med. 39(5), 17P (1998).
   Google Scholar
• Thomas JD, Griffin BP, White RD. Cardiac imaging techniques: which, when and why? Clev Ciin.j Med 63,213–220 (1996).
   Google Scholar
• Cleveley WO, Solovy A, White SE (Eds). The 1998 Out-patient Procedures Resource Book. The Center for Healthcare Industry Performance Studies, Columbus, OH, USA (1998).
   Google Scholar
• Matte GG, Barnes DC. Pharmacologic intervention in nuclear medicine assessment of cardiac perfusion. J. Pharm. Pharmaceut. Li. 4(3), 255–262 (2002).
   Google Scholar
• Garber AM, Solomon NA. Cost- effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann. Intern. Med. 130(9), 719–728 (1999).
   Google Scholar
• Assessing the validity and reliability of diagnostic and screening tests. In: Epidemiology Gordis L (Ed.). VVB Saunders Co., Philadelphia, PA, USA, 58–76 (1996).
   Google Scholar
• Gerson MC, Leppo JA, Corbett JR eta]. New tracers and new approaches. J. Nucl. Cardiol 1(1), 103–112 (1999).
   Google Scholar
• Dipyridamole. In: American Hospital Formulary Service Drug Information 2002. American Society of Health-Systems Pharmacists, Bethesda, MD, USA, 1892–1894 (2002).
   Google Scholar
• Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. Am. Coll. Cardiol. 23(2), 384–389 (1994).
   Google Scholar
• Polad JE, Wilson LM. Myocarclial infarction during adenosine stress test. Heart 87(2), E2 (2002).
   Google Scholar
• Khan IA, Samual SA. Stroke complicating adenosine perfusion imaging. Postgrad. Med. 73(864), 659–660 (1997).
   Google Scholar
• Lette J, Tatum JL, Fraser S et al. Safety of dipyridamole testing in 73,806 patients: the multicenter dipyridamole safety study. J. Nucl. Cardiol. 2(1), 3–17 (1995).
   Google Scholar
• Taillefer R, Amyot R, Turpin S, Lambert R, Pion C, Jarry M. Comparison between dipyridamole and adenosine as pharmacologic coronary vasodilators in detection of coronary artery disease with thallium 201 imaging. J. Nucl. Cardiol 3(3), 204–211 (1996).
   Google Scholar
• Treuth MG, Reyes GA, He ZX, Cwajg E, Mahmarian JJ, Verani MS. Tolerance and diagnostic accuracy of an abbreviated adenosine infusion for myocardial scintigraphy: a randomized, prospective study. Nucl. Carrlid. 8(5), 548–554 (2001).
   Google Scholar
• CardinalCHOICE® software. Cardinal Health Inc., Peabody, MA, USA.
   Google Scholar
• Hung JC, Mahoney DVV, Johnston DL, Gibbons RJ. An optimal dual-size system for the cost-effective usage of Adenoscan. Nucl Cardiol 5(2), 161–166 (1998).
   PubMedGoogle Scholar
• Hachamovitch R, Berman DS, Shaw LJ et al. Incremental prognostic value of myocardial perfusion single-photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocarclial infarction. Circulation 97(6), 535–543 (1998).
   PubMed Web of Science ®Google Scholar
• Sharir T, Germano G, Kang X et al. Prediction of myocardial infarction versus cardiac death by gated myocarclial perfusion SPECT. risk stratification by the amount of stress-induced ischaemia and the poststress ejection fraction. Nucl. Med. 42(6), 831–837 (2001).
   Google Scholar
• Amanullah AM, Berman DS, Erel J eta]. Incremental prognostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease. Am. Carrliol. 82(6), 725–730 (1998).
   Google Scholar
• Nallamothu N, Johnson JH, Bagheri B, Heo J, Iskandrian AE. Utility of stress single-photon emission computed tomography (SPECT) perfusion imaging in predicting outcome after coronary artery bypass grafting. Am.j Cardiol. 80(12), 1517–1521 (1997).
   Google Scholar
• Heller GV, Herman SD, Travin MI, Baron JI, Santos -Ocampo C, McClellan JR. Independent prognostic value of iv. dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. jAm. Coll. Carrliol. 26(5), 1202–1208 (1995).
   Google Scholar
• Ho KT, Miller TD, Christian TF, Hodge DO, Gibbons RJ. Prediction of severe coronary artery disease and long-term outcome in patients undergoing vasodilator SPECT. Nucl Cardiol. 8(4), 438–444 (2001).
   PubMedGoogle Scholar
• Chiamvimonvat V, Goodman SG, Langer A, Barr A, Freeman MR. Prognostic value of dipyridamole SPECT imaging in low-risk patients after myocardial infarction. J. Nucl. Carrliol. 8(2), 136–143 (2001).
   Google Scholar
• Vanzetto G, Halimi S, Hammoud T et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single -photon emission computed tomography. Diabetes Care 22(1), 19–26 (1999).
   Google Scholar
• Cohen MC, Curran PJ, LItalien GJ, Mittleman MA, Zarich SW Long-term prognostic value of preoperative dipyridamole thallium imaging and clinical indexes in patients with diabetes mellitus undergoing peripheral vascular surgery. Am. Carrliol. 83(7), 1038–1042 (1999).
   PubMedGoogle Scholar
• Gil VM, Almeida M, Ventosa A et al. Prognosis in patients with left bundle branch block and normal dipyridamole thallium-201 scintigraphy. J. Nucl. Cardiol. 5(4), 414–417 (1998).
   Google Scholar
• Miyagawa M, Mochizuki T, Murase K et al. Prognostic value of dipyridamole —thallium myocardial scintigraphy in patients with Kawasaki disease. Chrulation 98(10), 990–996 (1998).
   PubMedGoogle Scholar
• Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? Br. Med. .1320(7243), 1197–1200 (2000).
   Google Scholar
• Case series, editorials and reviews. In: Interpreting the Medical Literature. Gelbach SH (Ed.), McGraw-Hill Companies Inc., NY, USA, 245–266 (2002).
   Google Scholar
• Hurwitz R, Lyons K, Taketa R. Adenosine challenge and boost protocols: new tools for myocardial perfusion imaging. Clin. Nucl. Med 24(2), 92–93 (1999).
   Google Scholar
• Gao Z, Baker SP, Lasley RD et al. Novel short-acting A2a adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2a agonists. I Marmara Exp. Thor 298(1), 209–218 (2001).
   Google Scholar
• Glover DK, Ruiz M, Takehana K et al. Pharmacological stress myocardial perfusion imaging with the potent and selective A2a adenosine receptor agonists ATL193 and ATL146e administered by either iv. infusion or bolus injection. Chrulation 104(10), 1181–1187 (2001).
   Google Scholar